In Europe, Medtronic’s new Enlite sensor received CE mark approval for six-day wear and will be launched in over 35 countries outside of the US this spring.
More details here:
http://www.diatribe.us/issues/32/test-drive.php
In Europe, Medtronic’s new Enlite sensor received CE mark approval for six-day wear and will be launched in over 35 countries outside of the US this spring.
More details here:
http://www.diatribe.us/issues/32/test-drive.php
I’ve seen one review on it from a european user, so far sounds great!
The review makes it sound promising, I’m not sure about it taking a day to get “warmed up” though. That could get a bit old?
I mentioned the FDA to my endo yesterday about the Enlite and potential new Dex version. He was so angry he would not talk about it. He muttered something about “money” but I don’t know what he meant. He would not go further. He wears a MM pump and a Dex cgm. I don’t want to start any rumors, (as I write something inflammatory), but I am ticked because I was hoping for the Enlite for my first cgm. Now will start with dex. Too bad we can’t order the Veo and the Enlite from Europe! Don’t we get everything else from China? Why not Europe for this?!
I think he’s talking about the first 24 hours or so of a sensor when it’s still settling down and not as accurate. You’ll still get numbers earlier and if you’re a person who doesn’t have this issue with the current sensor I don’t think it’ll be a problem for you with the Enlite. The base chemistry shouldn’t be too radically different hopefully.
I had this issue a lot when I wore medtronic. I would get so many errors the first 12 to 16 hours I ended up putting in the sensor at night but leaving the CGMS off till the next morning. If I did that it worked fine. Something about my body chemistry didn’t like it so much. I have the same issue with Dex although not nearly to the degree I did with Minimed.
Looks like they fixed the large needle and discomfort. Performance might be on par with Dex overall and in some ways better. I really like that MM allows setting different high/low targets for nighttime vs daytime. They allow smaller (more customizable) increments for setting the targets, for Rise/Fall alerts, and for snooze time. The smaller receiver is also a major plus, imo.
The whole 3 day vs 6 day thing defies common sense. If FDA employees think they are doing well by us, they are kidding themselves. They should streamline and okay the necessary software change with no clinicals required. A 60 day delay at most
Another point. There is a lengthy review of Enlite use by a Greek contributor on insulinpumpers.org (Nikos). Or check Enlite sensors at insulinpumpforums.org for the whole copy of the review. Nikos thinks it is great. I never could find anything on the first site so the second is easier if not a regular at the former.
Here is a personal blog item from the UK on one person’s use of the Enlite:
http://www.shootuporputup.co.uk/2011/05/2938/
She used it for 12 days. Of course, we in the U.S. can only ‘window shop’ for now.